This announcement is a separate document:
百奥泰 关于BAT2206（乌司奴单抗）注射液上市许可申请获得受理的公告
Biotech's announcement on acceptance of the marketing license application for BAT2206 (usinumab) injection
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.